Pky.Ax
PKY.AX operates in the healthcare equipment industry, providing advanced medical equipment and technology solutions to healthcare providers and institutions.
Business. PKY.AX operates in the healthcare equipment industry, providing advanced medical equipment and technology solutions to healthcare providers and institutions.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
PKY.AX operates in the healthcare equipment industry, providing advanced medical equipment and technology solutions to healthcare providers and institutions.
The company's capital structure is highly leveraged, with total liabilities of 781,650 AUD and total equity of -268,370 AUD, resulting in a negative debt-to-equity ratio of -1.53. Liquidity is constrained, as evidenced by a current ratio of 0.64 and negative free cash flow of -1,444,910 AUD. Despite holding 107,500 AUD in cash and equivalents, the company's long-term debt of 411,730 AUD suggests a significant reliance on external financing.
Profitability is severely challenged, with a net loss of -1,447,740 AUD and an operating loss of -1,667,160 AUD. Return on equity is positive at 5.39%, but this is misleading due to the negative equity base. The return on assets is negative at -2.82%, indicating that the company is not generating returns sufficient to cover its asset base. These metrics fall well below the industry's preferred performance benchmarks for profitability and returns.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific risks and limits the ability to offset losses in one area with gains in another.
Growth is not evident in the current financial period, with a reported revenue of 27,780 AUD. Analyst estimates suggest a decline in revenue to 250,000 AUD, indicating a significant drop in performance. The company's capital expenditure of -4,620 AUD is minimal, suggesting limited investment in future growth.
The company faces significant liquidity and solvency risks, with a negative net cash position and a high debt burden. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative equity and operating cash flow suggest a high risk of insolvency. No dilution adjustments have been applied to the valuation metrics, indicating that the current capital structure is stable.
Recent financial filings and transcripts indicate a challenging operating environment, with the company reporting a significant net loss and negative cash flows. The company's ability to meet its financial obligations is in question, and there are no indications of near-term improvements in its financial performance.
- The company is operating at a significant net loss and has negative equity, indicating severe financial distress.
- Liquidity is constrained, with a current ratio of 0.64 and negative free cash flow.
- Profitability metrics are poor, with a negative return on assets and a misleadingly positive return on equity due to negative equity.
- The company's growth trajectory is negative, with a decline in revenue and minimal capital expenditure.
- The company faces high liquidity and solvency risks, with a negative net cash position and a high debt burden.
- There are no indications of near-term improvements in financial performance based on recent filings and transcripts.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- PKY.AX Market data — financials · 2026-05-29
- Pathkey.AI Ltd Market data — analyst estimates · 2026-05-29